Univasc 7.5 mg Tablet Recall: Failed Dissolution Testing
UCB, Inc. recalls Univasc (moexipril HCl) 7.5 mg tablets due to failed dissolution testing. Check your lot number and expiry date for details.
Use caution until it’s fixed
Failed Dissolution Testing: Failed 24 month dissolution testing.
Contact the company
What happened, in plain English
UCB, Inc. is recalling a specific batch of Univasc (moexipril HCl) 7.5 mg tablets because they failed 24-month dissolution testing. This means the medication may not release its active ingredient properly, potentially affecting how well it works for patients. The recall affects 2,916 bottles distributed nationwide. Read more at govinfonow.com/recall/43921-ucb-inc-recalls-univasc-moexipril-hcl-tablets-7-5-mg.
Source Summary by GovInfoNow · govinfonow.com/recall/43921-ucb-inc-recalls-univasc-moexipril-hcl-tablets-7-5-mg · Updated October 12, 2026 · FDA enforcement record: FDA #D-1348-2015
Cite this page
“Univasc 7.5 mg Tablet Recall: Failed Dissolution Testing.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43921-ucb-inc-recalls-univasc-moexipril-hcl-tablets-7-5-mg. Based on FDA recall #D-1348-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1348-2015%22&limit=1).
Why it’s dangerous
The tablets failed dissolution testing, which is a measure of how well a drug breaks down and releases its active ingredient in the body. If the tablet does not dissolve correctly, the patient may receive less than the prescribed dose, leading to ineffective treatment for their condition.
Who’s affected
Patients currently taking Univasc (moexipril HCl) 7.5 mg tablets who purchased the recalled lot are at risk of receiving medication that may not function as intended.
How to tell if you have this one
Check if you have Univasc (moexipril HCl) tablets, 7.5 mg, in a 100 Ct Bottle with NDC 0091-3707-01. Specifically, look for Lot # 98016P1 with an expiry date of April, 2016.
- Brand
Univasc- Category
Drug
What to do — step by step
Check Your Medication
Verify if your bottle matches the recalled NDC 0091-3707-01 and Lot # 98016P1 with an April, 2016 expiry.
Contact Your Pharmacist
Speak with your pharmacist or healthcare provider to determine the next steps for replacing this medication.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1348-2015 (July 24, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1348-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.